These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11358326)

  • 1. Neurotransmitter transporters synthesis and degradation rates.
    Kimmel H; Vicentic A; Kuhar MJ
    Life Sci; 2001 Apr; 68(19-20):2181-5. PubMed ID: 11358326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76.
    Kimmel HL; Carroll FI; Kuhar MJ
    Neuropharmacology; 2000 Feb; 39(4):578-85. PubMed ID: 10728879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin transporter production and degradation rates: studies with RTI-76.
    Vicentic A; Battaglia G; Carroll FI; Kuhar MJ
    Brain Res; 1999 Sep; 841(1-2):1-10. PubMed ID: 10546982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged dopamine and serotonin transporter inhibition after exposure to tropanes.
    Bennett BA; Hollingsworth CK; Martin RS; Childers SR; Ehrenkaufer RE; Porrino LJ; Davies HM
    Neuropharmacology; 1998; 37(1):123-30. PubMed ID: 9680265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal from repeated cocaine alters dopamine transporter protein turnover in the rat striatum.
    Kimmel HL; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 2003 Jan; 304(1):15-21. PubMed ID: 12490570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission.
    Wu Q; Reith ME; Kuhar MJ; Carroll FI; Garris PA
    J Neurosci; 2001 Aug; 21(16):6338-47. PubMed ID: 11487657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.
    Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ
    Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct approach for attenuating cocaine's effects on extracellular dopamine: targeting the dopamine transporter.
    Morgan AE; Porter SP; Clarkson FA; Volkow ND; Fowler JS; Dewey SL
    Synapse; 1997 Aug; 26(4):423-7. PubMed ID: 9215601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-affinity binding of [125I]RTI-55 to dopamine and serotonin transporters in rat brain.
    Boja JW; Mitchell WM; Patel A; Kopajtic TA; Carroll FI; Lewin AH; Abraham P; Kuhar MJ
    Synapse; 1992 Sep; 12(1):27-36. PubMed ID: 1411961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [125I]RTI-55: a potent ligand for dopamine transporters.
    Boja JW; Patel A; Carroll FI; Rahman MA; Philip A; Lewin AH; Kopajtic TA; Kuhar MJ
    Eur J Pharmacol; 1991 Feb; 194(1):133-4. PubMed ID: 2060590
    [No Abstract]   [Full Text] [Related]  

  • 11. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride].
    Fleckenstein AE; Pögün S; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):200-6. PubMed ID: 8858994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters.
    Kokoshka JM; Vaughan RA; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 1998 Nov; 361(2-3):269-75. PubMed ID: 9865517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
    Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
    Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
    Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing effects of clomipramine on [125I]RTI-55 and [3H]N-methylspiperone binding in mouse striatum: important role of other factors than endogenous dopamine?
    Inoue O; Kobayashi K; Hosoi R; Gee A
    Synapse; 1998 Nov; 30(3):338-40. PubMed ID: 9776138
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
    Wall SC; Innis RB; Rudnick G
    Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the biogenic amine transporters. V. Demonstration of two binding sites for the cocaine analog [125I]RTI-55 associated with the 5-HT transporter in rat brain membranes.
    Silverthorn ML; Dersch CM; Baumann MH; Cadet JL; Partilla JS; Rice KC; Carroll FI; Becketts KM; Brockington A; Rothman RB
    J Pharmacol Exp Ther; 1995 Apr; 273(1):213-22. PubMed ID: 7714769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain.
    Little KY; Kirkman JA; Carroll FI; Breese GR; Duncan GE
    J Neurochem; 1993 Dec; 61(6):1996-2006. PubMed ID: 8245956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
    Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
    J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine self-administration in rats differentially alters mRNA levels of the monoamine transporters and striatal neuropeptides.
    Arroyo M; Baker WA; Everitt BJ
    Brain Res Mol Brain Res; 2000 Nov; 83(1-2):107-20. PubMed ID: 11072100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.